Qualified Consideration. Buyer shall pay Seller an amount equal to [****] percent ([****]%) of all Qualified Consideration received pursuant to any Qualified Consideration Agreement; provided that if Buyer or its Affiliates enter into the Qualified Consideration Agreement after the Completion of the first Phase III Clinical Trial for a Product, then all such amounts paid to Seller shall be creditable against future milestones related to the applicable Product which are due to Seller in accordance with Section 3.2 or Section 3.4.
Appears in 4 contracts
Samples: Asset Purchase Agreement (Macrogenics Inc), Patent Assignment Agreement (Provention Bio, Inc.), Patent Assignment Agreement (Provention Bio, Inc.)
